TSX News -
Trillium Reports Annual 2016 Financial and Operating Results
TORONTO, ONTARIO–(Marketwired – March 10, 2017) – Trillium Therapeutics Inc. (NASDAQ:TRIL)(TSX:TRIL), a clinical stage immuno-oncology company developing innovative therapies [...]